Carpal tunnel syndrome commonly occurs in individuals working in occupations that involve use of vibrating manual tools or tasks with highly repetitive and forceful manual exertion. In recent years, carpal tunnel syndrome has been evaluated by ultrasound imaging that monitors median nerve movement. Conventional image analysis methods, such as the active contour model, are typically used to expedite automatic segmentation of the median nerve, but these usually suffer from an arduous manual intervention. We propose a new convolutional neural network framework for localization and segmentation of the median nerve, called DeepNerve, that is based on the U-Net model. DeepNerve integrates the characteristics of MaskTrack and convolutional long short-term memory to effectively locate and segment the median nerve. On the basis of experimental results, the proposed model achieved high performance and generated average Dice measurement, precision, recall and F-score values of 0.8975, 0.8912, 0.9119 and 0.9015, respectively. The segmentation results of DeepNerve were significantly improved in comparison with those of conventional active contour models. Additionally, the results of Student's t-test revealed significant differences in four deformation measurements of the median nerve, including area, perimeter, aspect ratio and circularity. We conclude that the proposed DeepNerve not only generates satisfactory results for localization and segmentation of the median nerve, but also creates more promising measurements for applications in clinical carpal tunnel syndrome diagnosis.
Rapid detection of bacteria and their susceptibility to specific antibiotics plays a vital role in microbial infection treatments. Antimicrobial susceptibility testing (AST) is a common measure to select effective drugs. However, the conventional practices, such as broth dilution, E-test, and disk diffusion, in clinical applications require a long turnaround time (∼3 days), thereby compromising treatments and increasing mortality. This study presents self-powered sensors for on-site microorganism monitoring and rapid AST based on functionalized microbeads. The microbead sensors are driven by Brownian motion, rendering external power unnecessary. Fluorescent microbeads (dp = 2 μm) were coated with vancomycin to capture bacteria. The growth and responses of Gram-negative Escherichia coli and Gram-positive Staphylococcus aureus under antibiotic treatment were evaluated. The method showed stable selective binding despite the presence of some interferential substances, such as proteins and cells. Diffusivity change was strongly related to bacterial concentration. Accordingly, the diffusivity values of microbeads bound with motile and nonmotile bacteria exhibited specific patterns because of extra motility from microbes and increased particle diameter. Only a drop of microbead–bacteria suspension (∼5 μL) was needed in a microchip for each measurement. The microchip provided a steady environment for measurement over a few hours. By distinguishing the slope of the last four data points in the temporal diffusivity curve, bacterial susceptibility or resistance to specific antibiotics could be determined within a time frame of 2 h. The study provides insights into saving more lives by using a fast and robust AST technique in future clinical practice.